Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Eva M. Bongers"'
Autor:
David A. Palma, Eva M. Bongers, Andrew Warner, Suresh Senan, C.J.A. Haasbeek, J.R. van Sornsen de Koste, Merle I. Ronden, Berend J. Slotman, Gerrit J. Blom, Aaron D. Ward, Carol Johnson, Femke O.B. Spoelstra
Publikováno v:
International Journal of Radiation Oncology Biology Physics, 100(1), 115-121. Elsevier Inc.
Ronden, M I, van Sörnsen de Koste, J R, Johnson, C, Slotman, B J, Spoelstra, F O B, Haasbeek, C J A, Blom, G, Bongers, E M, Warner, A, Ward, A, Palma, D & Senan, S 2018, ' Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer ', International Journal of Radiation Oncology Biology Physics, vol. 100, no. 1, pp. 115-121 . https://doi.org/10.1016/j.ijrobp.2017.09.035
Ronden, M I, van Sörnsen de Koste, J R, Johnson, C, Slotman, B J, Spoelstra, F O B, Haasbeek, C J A, Blom, G, Bongers, E M, Warner, A, Ward, A, Palma, D & Senan, S 2018, ' Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer ', International Journal of Radiation Oncology Biology Physics, vol. 100, no. 1, pp. 115-121 . https://doi.org/10.1016/j.ijrobp.2017.09.035
PURPOSE: To investigate, in the setting of stereotactic ablative radiation therapy (SABR) for early-stage non-small cell lung cancer, the incidence and patterns of change in high-risk radiologic features (HRFs) in patients known to have no local recu
Autor:
Wilko F.A.R. Verbakel, Cornelis J.A. Haasbeek, Suresh Senan, Angela Botticella, Umberto Ricardi, David A. Palma, Ben J. Slotman, Andrew Warner, Eva M. Bongers
Publikováno v:
Bongers, E M, Botticella, A, Palma, D A, Haasbeek, C J A, Warner, A, Verbakel, W F A R, Slotman, B, Ricardi, U & Senan, S 2013, ' Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs ', Radiotherapy and Oncology, vol. 109, no. 1, pp. 95-99 . https://doi.org/10.1016/j.radonc.2013.10.011
Radiotherapy and Oncology, 109(1), 95-99. Elsevier Ireland Ltd
Radiotherapy and Oncology, 109(1), 95-99. Elsevier Ireland Ltd
Purpose To identify dosimetric factors that predict development of radiation pneumonitis (RP) following stereotactic or hypofractionated radiotherapy for lung tumors. Methods Seventy-nine consecutive patients with either a planning target volume (PTV
Autor:
Max Dahele, Adrianus J. de Langen, Ben J. Slotman, Esther J. Nossent, Eva M. Bongers, Niels Haasbeek, H. Tekatli, Femke O.B. Spoelstra, Suresh Senan, Sayed M.S. Hashemi, Wilko F.A.R. Verbakel, Patricia F. de Haan
Publikováno v:
Journal of Thoracic Oncology, 11(7), 1081-1089. International Association for the Study of Lung Cancer
Tekatli, H, Haasbeek, N, Dahele, M, De Haan, P, Verbakel, W, Bongers, E, Hashemi, S, Nossent, E, Spoelstra, F, de Langen, A J, Slotman, B & Senan, S 2016, ' Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with "Ultracentral" Non-Small Cell Lung Cancer ', Journal of Thoracic Oncology, vol. 11, no. 7, pp. 1081-1089 . https://doi.org/10.1016/j.jtho.2016.03.008
Tekatli, H, Haasbeek, N, Dahele, M, De Haan, P, Verbakel, W, Bongers, E, Hashemi, S, Nossent, E, Spoelstra, F, de Langen, A J, Slotman, B & Senan, S 2016, ' Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with "Ultracentral" Non-Small Cell Lung Cancer ', Journal of Thoracic Oncology, vol. 11, no. 7, pp. 1081-1089 . https://doi.org/10.1016/j.jtho.2016.03.008
Introduction We defined “ultracentral” lung tumors as centrally located non–small cell lung cancers with planning target volumes overlapping the trachea or main bronchi. Increased toxicity has been reported after both conventional and stereotac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::469c9802c566bef1a6a856f08fd2b1e3
https://research.vumc.nl/en/publications/11adee3f-be3b-46de-a29f-1756d8eb19ca
https://research.vumc.nl/en/publications/11adee3f-be3b-46de-a29f-1756d8eb19ca
Autor:
Umberto Ricardi, David A. Palma, W.F.A.R. Verbakel, Suresh Senan, Berend J. Slotman, Angela Botticella, C.J.A. Haasbeek, Eva M. Bongers, Andrew Warner
Publikováno v:
Radiotherapy and Oncology. 106
Publikováno v:
International journal of radiation oncology, biology, physics. 82(1)
Autor:
Max Dahele, Suresh Senan, C.J.A. Haasbeek, Eva M. Bongers, Berend J. Slotman, W.F.A.R. Verbakel, P.F. de Haan
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 84:S549-S550
Autor:
Suresh Senan, Umberto Ricardi, Eva M. Bongers, C.J.A. Haasbeek, Berend J. Slotman, Andrew Warner, Angela Botticella, W.F.A.R. Verbakel, David A. Palma
Publikováno v:
Lung Cancer. 80:S23
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 81:S162
Publikováno v:
Journal of Thoracic Oncology, 6(12), 2052-2057. International Association for the Study of Lung Cancer
Bongers, E M, Haasbeek, C J A, Lagerwaard, F J, Slotman, B J & Senan, S 2011, ' Incidence and Risk Factors for Chest Wall Toxicity After Risk-Adapted Stereotactic Radiotherapy for Early-Stage Lung Cancer ', Journal of Thoracic Oncology, vol. 6, no. 12, pp. 2052-2057 . https://doi.org/10.1097/JTO.0b013e3182307e74
Bongers, E M, Haasbeek, C J A, Lagerwaard, F J, Slotman, B J & Senan, S 2011, ' Incidence and Risk Factors for Chest Wall Toxicity After Risk-Adapted Stereotactic Radiotherapy for Early-Stage Lung Cancer ', Journal of Thoracic Oncology, vol. 6, no. 12, pp. 2052-2057 . https://doi.org/10.1097/JTO.0b013e3182307e74
Introduction: High local control rates are reported after stereotactic ablative body radiotherapy (SABR) in stage I non-small cell lung cancer. Toxicity is uncommon, but few reports on long-term follow-up are available. We studied the incidence of ch